Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
9,850.00
-200.00 (-1.99%)
Jun 27, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 225.60 billion as of June 27, 2025. Its market cap has decreased by -48.50% in one year.
Market Cap
225.60B
Enterprise Value
187.55B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
9,850.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 225.60B, an increase of 40.79%. That is a compound annual growth rate of 7.48%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jun 18, 2025 | 225.60B | -5.93% |
Dec 30, 2024 | 239.82B | -53.54% |
Dec 28, 2023 | 516.20B | -0.71% |
Dec 29, 2022 | 519.87B | -21.31% |
Dec 30, 2021 | 660.68B | -73.75% |
Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Samsung Electronics | 391.17T |
SK hynix | 196.06T |
Samsung Biologics | 71.46T |
LG Energy Solution | 67.39T |
Hyundai Motor Company | 45.04T |
Doosan Enerbility | 42.14T |
Hanwha Aerospace | 41.99T |
Kia Corporation | 38.55T |